| Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease | New England Journal of Medicine | 2017 | 3.9K |
| Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas | New England Journal of Medicine | 2017 | 951 |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease | Nature Genetics | 2017 | 508 |
| Health-Related Quality of Life Outcomes in PARADIGM-HF | Circulation: Heart Failure | 2017 | 91 |
| Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR, HER2 advanced breast cancer: results from BOLERO-2 | British Journal of Cancer | 2017 | 82 |
| Updated report on tools to measure outcomes of clinical trials in fragile X syndrome | Journal of Neurodevelopmental Disorders | 2017 | 81 |
| Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016 | Antimicrobial Agents and Chemotherapy | 2017 | 73 |
| International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome | Arthritis Care and Research | 2017 | 55 |
| Skin penetration and tissue permeation after topical administration of diclofenac | Current Medical Research and Opinion | 2017 | 53 |
| Clear or almost clear skin improves the quality of life in patients with moderate-to-severe psoriasis: a systematic review and meta-analysis | Journal of the European Academy of Dermatology and Venereology | 2017 | 43 |
| Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity | Neuropsychiatric Disease and Treatment | 2017 | 39 |
| NMR and MS Methods for Metabolomics | Methods in Molecular Biology | 2017 | 38 |
| Tutorial on statistical considerations on subgroup analysis in confirmatory clinical trials | Statistics in Medicine | 2017 | 32 |
| Efficacy and Safety of Crystalline Valsartan/Sacubitril (LCZ696) Compared With Placebo and Combinations of Free Valsartan and Sacubitril in Patients With Systolic Hypertension: The RATIO Study | Journal of Cardiovascular Pharmacology | 2017 | 28 |
| α4-integrin receptor desaturation and disease activity return after natalizumab cessation | Neurology: Neuroimmunology and NeuroInflammation | 2017 | 18 |
| Regional Ventilation Changes in the Lung: Treatment Response Mapping by Using Hyperpolarized Gas MR Imaging as a Quantitative Biomarker | Radiology | 2017 | 16 |
| Clinical and Patient-reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry | Journal of Rheumatology | 2017 | 11 |
| Treatment-free interval as a metric of patient experience and a health outcome of value for advanced multiple myeloma: the case for the histone deacetylase inhibitor panobinostat, a next-generation novel agent | Expert Review of Hematology | 2017 | 8 |
| Circulating tumor DNA as a novel tool to shape clinical trial designs with the potential to impact outcomes: a focus on PI3K inhibitors | Annals of Oncology | 2017 | 6 |
| Adaptive Optimal Designs for Dose-Finding Studies with Time-to-Event Outcomes | AAPS Journal | 2017 | 6 |
| All-Cause and Acute Pancreatitis Health Care Costs in Patients With Severe Hypertriglyceridemia | Pancreas | 2017 | 6 |
| Everolimus Effect on Gastrin and Glucagon in Pancreatic Neuroendocrine Tumors | Pancreas | 2017 | 3 |
| Phase 2 trial (BRF113928) of dabrafenib (D) plus trametinib (T) in patients (pts) with previously untreated BRAF V600E–mutant metastatic non-small cell lung cancer (NSCLC) | Annals of Oncology | 2017 | 3 |
| COMBI-AD: Adjuvant dabrafenib (D) plus trametinib (T) for resected stage III BRAF V600E/K–mutant melanoma | Annals of Oncology | 2017 | 3 |
| Role of Cost-Sharing Subsidies on the Initiation of and Adherence to Tyrosine Kinase Inhibitor Therapy by Medicare Beneficiaries With Chronic Myeloid Leukemia | Journal of Clinical Oncology | 2017 | 2 |
